In the third panel from the left, the Doxil treatment group’s tumor tissue seems to show slightly reduced cancer cell density and lower Ki67 but slightly higher cleaved caspase-3 levels relative to the left panel, indicating the limited antitumor effect by Doxil. This evidence concerns the gene MKI67 and neoplasm.